Polaryx Therapeutics (PLYX) News
NASDAQ: PLYXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PLYX news summary
We found 2 recent headlines mentioning Polaryx Therapeutics (PLYX): 1 in the past week and 2 in the past 30 days, most often from GlobeNewswire. PLYX is making an outsized move today, down 11.92% at $1.33, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Polaryx Therapeutics Highlights Participation in NCL Scientific Conference and NTSAD Imagine & Believe Event", was published by GlobeNewswire on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Polaryx Therapeutics headlines
- Polaryx Therapeutics Highlights Participation in NCL Scientific Conference and NTSAD Imagine & Believe EventScientific presentation and patient advocacy engagement follow activation of the first clinical trial site for SOTERIA Scientific presentation and patient advocacy engagement follow activation of the…GlobeNewswire
- Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200Boys Town National Research Hospital in Nebraska becomes first activated site in study targeting four rare pediatric lysosomal storage disorders and has now initiated patient screening as Polaryx…GlobeNewswire